Mass Screening of SARS-CoV-2 Variants using Sanger Sequencing Strategy in Hiroshima, Japan.
Ko K, Takahashi K, Nagashima S, E B, Ouoba S, Hussain MRA, Akita T, Sugiyama A, Sakaguchi T, Tahara H, Ohge H, Ohdan H, Kubo T, Ishikawa N, Takafuta T, Fujii Y, Mimori M, Okada F, Kishita E, Ariyoshi K, Kuwabara M, Tanaka J.
Ko K, et al. Among authors: kishita e.
Sci Rep. 2022 Feb 14;12(1):2419. doi: 10.1038/s41598-022-04952-2.
Sci Rep. 2022.
PMID: 35165301
Free PMC article.